Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases
- 1 May 2010
- journal article
- Published by Wiley in Veterinary and Comparative Oncology
- Vol. 8 (3), 196-208
- https://doi.org/10.1111/j.1476-5829.2010.00222.x
Abstract
A dose-intensified/dose-dense chemotherapy protocol for canine lymphoma was designed and implemented at the Veterinary Hospital of the University of Pennsylvania. In this study, we describe the clinical characteristics, prognostic factors, efficacy and toxicity in 130 dogs treated with this protocol. The majority of the dogs had advanced stage disease (63.1% stage V) and sub-stage b (58.5%). The median time to progression (TTP) and lymphoma-specific survival were 219 and 323 days, respectively. These results are similar to previous less dose-intense protocols. Sub-stage was a significant negative prognostic factor for survival. The incidence of toxicity was high; 53.9 and 45% of the dogs needed dose reductions and treatment delays, respectively. Dogs that required dose reductions and treatment delays had significantly longer TTP and lymphoma-specific survival times. These results suggest that dose density is important, but likely relative, and needs to be adjusted according to the individual patient's toxicity for optimal outcome.Keywords
This publication has 27 references indexed in Scilit:
- Comparison of 3 Protocols for Treatment after Induction of Remission in Dogs with LymphomaJournal of Veterinary Internal Medicine, 2007
- Comparison of COAP and UW‐19 Protocols for Dogs with Multicentric LymphomaJournal of Veterinary Internal Medicine, 2007
- Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” LymphomaJournal of Clinical Oncology, 2002
- Evaluation of a 6‐Month Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2002
- Evaluation of a Discontinuous Treatment Protocol (VELCAP‐S) for Canine LymphomaJournal of Veterinary Internal Medicine, 2001
- Evaluation of a High‐Dose Chemotherapy Protocol with No Maintenance Therapy for Dogs with LymphomaJournal of Veterinary Internal Medicine, 2000
- Evaluation of Prognostic Factors and Sequential Combination Chemotherapy With Doxorubicin for Canine LymphomaJournal of Veterinary Internal Medicine, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphomaInternational Journal of Hyperthermia, 1992
- Is Maintenance Chemotherapy Appropriate for the Management of Canine Malignant Lymphoma?Journal of Veterinary Internal Medicine, 1992